[Industry Voice #28] Craig Lipset on FDA’s Quotes | Big Pharma Standpoint | DCTs 

Decentralized trials have become a prominent trend in the sphere of clinical research. Recent advancements in #AI and overall #Digitalization have further accelerated the process of decentralization. Join us for an insightful interview with Craig Lipset, a leading figure in digital R&D innovations in the life science industry, CEO & Founder of Clinical Innovation Partners. Explore the current state of decentralized trials, the role of AI and wearables, overcoming barriers to universal adoption, FDA's perspective, patient enrollment and many other related topics in our new #IndustryVoice video podcast episode.
0:00 Introduction
1:21 The status of decentralized clinical trials
4:05 AI in fostering decentralization
7:09 Universal shift to innovative solutions
11:59 FDA’s approach to decentralized studies
15:19 Tipps for patients’ engagement in DCT
18:16 Enrollment via social media channels
20:08 Telemedicine in DCT
23:55 Future of the industry
Enjoy and subscribe to our RU-vid channel to be the first to know about new content on clinical research.
Webpage: oct-clinicaltrials.com/.
Experience: oct-clinicaltrials.com/oct-ex....
Blog, articles, case studies: oct-clinicaltrials.com/resources.
LinkedIn: / oct-clinical-trials-in...
✉Reach out to become the next speaker: pr@oct-clinicaltrials.com
✉Submit an RFP for clinical services: info@oct-clinicaltrials.com
#cro #octclinical #decentralizedclinicaltrials #decentralization #aiclinicaltrials #craiglipset #fda

Наука